Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Array Biopharma
Array Biopharma
(ARRY)
Array BioPharma is an American clinical stage, pharmaceutical company that focuses on oncology medication headquartered in Boulder, Colorado. The company is a subsidiary of Pfizer.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Braftovi
Encorafenib
2018-06-27
2029-2033
Colorectal neoplasms
,
Melanoma
Mektovi
Binimetinib
2018-06-27
2023-2033
Melanoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Binimetinib
colorectal neoplasms
,
colonic neoplasms
,
rectal neoplasms
,
gastrointestinal stromal tumors
,
disease progression
,
gene rearrangement
,
bcr-abl positive chronic myelogenous leukemia
,
lung neoplasms
,
non-small-cell lung carcinoma
,
melanoma
,
neoplasms
,
leukemia
,
myeloid leukemia
,
carcinoma
,
breast neoplasms
,
triple negative breast neoplasms
,
invasive hydatidiform mole
,
plexiform neurofibroma
,
neurofibromatosis 1
,
neurofibromatoses
,
neurofibroma
,
cutaneous malignant melanoma
,
multiple myeloma
,
plasma cell neoplasms
,
myeloid leukemia acute
,
biliary tract neoplasms
,
lymphoma
Encorafenib
melanoma
,
colorectal neoplasms
,
neoplasm metastasis
,
multiple myeloma
,
plasma cell neoplasms
Sacituzumab
esophageal neoplasms
,
neoplasms
,
esophageal squamous cell carcinoma
,
colorectal neoplasms
,
pancreatic ductal carcinoma
,
biliary tract neoplasms
,
urologic neoplasms
,
transitional cell carcinoma
,
non-muscle invasive bladder neoplasms
,
non-small-cell lung carcinoma
,
triple negative breast neoplasms
,
breast neoplasms
,
lung neoplasms
,
endometrial neoplasms
,
uterine cervical neoplasms
,
ovarian neoplasms
,
carcinoma
,
fallopian tube neoplasms
,
urinary bladder neoplasms
Ivuxolimab
lymphoma
,
follicular lymphoma
,
carcinoma
,
breast neoplasms
,
triple negative breast neoplasms
,
invasive hydatidiform mole
,
neoplasms
,
ovarian neoplasms
,
non-small-cell lung carcinoma
Utomilumab
follicular lymphoma
,
renal cell carcinoma
,
non-hodgkin lymphoma
,
squamous cell carcinoma of head and neck
,
melanoma
,
breast neoplasms
,
carcinoma
,
triple negative breast neoplasms
,
invasive hydatidiform mole
,
oropharyngeal neoplasms
,
lip neoplasms
,
neoplasms
,
lymphoma
,
b-cell lymphoma
,
large b-cell lymphoma diffuse
,
non-small-cell lung carcinoma
,
ovarian neoplasms
Gilvetmab
lung neoplasms
,
small cell lung carcinoma
,
neoplasms
,
melanoma
,
urinary bladder neoplasms
,
esophageal squamous cell carcinoma
,
triple negative breast neoplasms
,
malignant mesothelioma
,
breast neoplasms
,
glioblastoma
,
colorectal neoplasms
,
pancreatic neoplasms
,
neoplasm metastasis
,
tumor virus infections
,
non-small-cell lung carcinoma
Varlitinib
pancreatic neoplasms
,
neoplasms
Buparlisib
melanoma
,
colorectal neoplasms
Edrecolomab
healthy volunteers/patients
,
diabetes mellitus
,
dyslipidemias
,
hemophilia a
Serine
geographic atrophy
,
atrophy
Bevifimod
phenylketonurias
FILANESIB
multiple myeloma
,
paraproteinemias
,
plasmacytoma
,
plasma cell leukemia
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
Nadide
diabetic neuropathies
,
neuralgia
,
postherpetic neuralgia
Nepidermin
pancreatic neoplasms
,
chronic hepatitis c
Polyglycolic acid
neoplasms
,
adenocarcinoma
,
neoplasm metastasis
,
stomach neoplasms
,
esophageal neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
colorectal neoplasms
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use